Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based Proteomics

Pancreatic cancer is one of the most lethal tumors, and reliable detection of early-stage pancreatic cancer and risk diseases for pancreatic cancer is essential to improve the prognosis. As 260 genes were previously reported to be upregulated in invasive ductal adenocarcinoma of pancreas (IDACP) cel...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:PLoS One
Κύριοι συγγραφείς: Yoneyama, Toshihiro, Ohtsuki, Sumio, Honda, Kazufumi, Kobayashi, Makoto, Iwasaki, Motoki, Uchida, Yasuo, Okusaka, Takuji, Nakamori, Shoji, Shimahara, Masashi, Ueno, Takaaki, Tsuchida, Akihiko, Sata, Naohiro, Ioka, Tatsuya, Yasunami, Yohichi, Kosuge, Tomoo, Kaneda, Takashi, Kato, Takao, Yagihara, Kazuhiro, Fujita, Shigeyuki, Huang, Wilber, Yamada, Tesshi, Tachikawa, Masanori, Terasaki, Tetsuya
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Public Library of Science 2016
Θέματα:
Research Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5007017/
https://ncbi.nlm.nih.gov/pubmed/27579675
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0161009
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια